Bridgeway Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4M | Buy |
112,076
+5,342
| +5% | +$1.18M | 0.49% | 44 |
|
|
2025
Q4 | $24.4M | Buy |
106,734
+7,453
| +8% | +$1.7M | 0.51% | 38 |
|
|
2025
Q3 | $23M | Sell |
99,281
-10,859
| -10% | -$2.21M | 0.49% | 23 |
|
|
2025
Q2 | $20.4M | Buy |
+110,140
| New | +$20.5M | 0.49% | 38 |
|
|
2024
Q3 | – | Sell |
-1,559
| Closed | -$267K | – | 1255 |
|
|
2024
Q2 | $267K | Hold |
1,559
| – | – | 0.01% | 991 |
|
|
2024
Q1 | $284K | Hold |
1,559
| – | – | 0.01% | 1048 |
|
|
2023
Q4 | $242K | Sell |
1,559
-300
| -16% | -$43.7K | 0.01% | 1101 |
|
|
2023
Q3 | $277K | Hold |
1,859
| – | – | 0.01% | 1029 |
|
|
2023
Q2 | $250K | Hold |
1,859
| – | – | 0.01% | 1083 |
|
|
2023
Q1 | $296K | Hold |
1,859
| – | – | 0.01% | 1010 |
|
|
2022
Q4 | $300K | Hold |
1,859
| – | – | 0.01% | 988 |
|
|
2022
Q3 | $249K | Hold |
1,859
| – | – | 0.01% | 1091 |
|
|
2022
Q2 | $285K | Hold |
1,859
| – | – | 0.01% | 1004 |
|
|
2022
Q1 | $301K | Hold |
1,859
| – | – | 0.01% | 1078 |
|
|
2021
Q4 | $252K | Hold |
1,859
| – | – | ﹤0.01% | 1129 |
|
|
2021
Q3 | $201K | Hold |
1,859
| – | – | ﹤0.01% | 1203 |
|
|
2021
Q2 | $209K | Sell |
1,859
-19,400
| -91% | -$2.18M | ﹤0.01% | 1254 |
|
|
2021
Q1 | $2.3M | Hold |
21,259
| – | – | 0.04% | 548 |
|
|
2020
Q4 | $2.28M | Sell |
21,259
-20,300
| -49% | -$1.95M | 0.05% | 478 |
|
|
2020
Q3 | $3.64M | Sell |
41,559
-156,300
| -79% | -$14.7M | 0.08% | 254 |
|
|
2020
Q2 | $19.4M | Buy |
+197,859
| New | +$17.4M | 0.39% | 88 |
|
|
2018
Q4 | – | Sell |
-98,700
| Closed | -$9.34M | – | 1365 |
|
|
2018
Q3 | $9.34M | Sell |
98,700
-50,100
| -34% | -$4.75M | 0.09% | 184 |
|
|
2018
Q2 | $13.8M | Buy |
148,800
+600
| +0.4% | +$58.6K | 0.14% | 140 |
|
|
2018
Q1 | $14M | Buy |
148,200
+46,500
| +46% | +$5.11M | 0.15% | 119 |
|
|
2017
Q4 | $9.84M | Buy |
+101,700
| New | +$9.58M | 0.11% | 159 |
|
|
2016
Q3 | – | Sell |
-4,000
| Closed | -$248K | – | 1422 |
|
|
2016
Q2 | $248K | Hold |
4,000
| – | – | ﹤0.01% | 1261 |
|
|
2016
Q1 | $228K | Hold |
4,000
| – | – | ﹤0.01% | 1279 |
|
|
2015
Q4 | $237K | Hold |
4,000
| – | – | ﹤0.01% | 1261 |
|
|
2015
Q3 | $218K | Hold |
4,000
| – | – | ﹤0.01% | 1290 |
|
|
2015
Q2 | $269K | Buy |
+4,000
| New | +$261K | 0.01% | 1279 |
|
|
2014
Q1 | – | Sell |
-10,960
| Closed | -$579K | – | 1413 |
|
|
2013
Q4 | $579K | Sell |
10,960
-235,060
| -96% | -$11.6M | 0.02% | 968 |
|
|
2013
Q3 | $11M | Buy |
246,020
+4,090
| +2% | +$181K | 0.38% | 41 |
|
|
2013
Q2 | $10M | Buy |
+241,930
| New | +$10.6M | 0.4% | 37 |
|
Other funds holding ABBV
VCM
VPM
Bridgeway Capital Management's ABBV Position: Q1 2026 in Review
Bridgeway Capital Management increased its AbbVie (ABBV) stake by 5% in Q1 2026, buying an estimated $1.18M and bringing the position to 112,076 shares worth $24.4M. The position accounts for 0.49% of the portfolio, ranked #44.
Bridgeway Capital Management first reported a position in ABBV in Q2 2013 and has held it in 33 quarters since. The position peaked at $24.4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bridgeway Capital Management held 112,076 shares of AbbVie worth $24.4M as of Q1 2026.
- Bridgeway Capital Management bought 5,342 AbbVie shares in Q1 2026, an estimated $1.18M.
- AbbVie made up 0.49% of Bridgeway Capital Management's portfolio in Q1 2026, its #44 holding.
- Bridgeway Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 33 quarters since.
- Bridgeway Capital Management's AbbVie position peaked at $24.4M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.